Empleos de bio tech en Barcelona

Who we areAt Neuroelectrics® we are on a mission to change brain health forever. We design and manufacture wearable medical devices that monitor and modulate brain activity — combining high-density EEG with non-invasive neurostimulation to help researchers and clinicians tackle some of the most challenging neurological and psychiatric conditions, from...

It currently takes over 10 years and $1.3B to develop a drug. More than 70% of that investment goes into clinical trials, yet only ~10% of candidates make it from Phase I to approval.Evinova a new health-tech business is here to change the math. We use advanced algorithms and GenAI to aim high: boosting clinical trial success by 20%, cutting development time...

It currently takes over 10 years and $1.3B to develop a drug. More than 70% of that investment goes into clinical trials, yet only ~10% of candidates make it from Phase I to approval.Evinova a new health-tech business is here to change the math. We use advanced algorithms and GenAI to aim high: boosting clinical trial success by 20%, cutting development time...

It currently takes over 10 years and $1.3B to develop a drug. More than 70% of that investment goes into clinical trials, yet only ~10% of candidates make it from Phase I to approval. Evinova a new health-tech business is here to change the math. We use advanced algorithms and GenAI to aim high: boosting clinical trial success by 20%, cutting...

It currently takes over 10 years and $1.3B to develop a drug. Si cree que es el candidato ideal para la siguiente oportunidad, envíe su solicitud después de leer la descripción completa. More than 70% of that investment goes into clinical trials, yet only ~10% of candidates make it from Phase I to approval. Evinova a new health-tech business is here...

Are you ready to be part of the future of healthcare? Can you think big, be bold, and harness the power of digital and AI to tackle one of the most stubborn problems in regulated software engineering — knowing, with confidence, that what you shipped works? Then Evinova, a health tech business part of the AstraZeneca Group, might be for you. We are...

Are you ready to be part of the future of healthcare? Can you think big, be bold, and harness the power of digital and AI to tackle one of the most stubborn problems in regulated software engineering — knowing, with confidence, that what you shipped works? Then Evinova, a health tech business part of the AstraZeneca Group, might be for you. We are...

Are you ready to be part of the future of healthcare? Can you think big, be bold, and harness the power of digital and AI to tackle one of the most stubborn problems in regulated software engineering — knowing, with confidence, that what you shipped works? Then Evinova, a health tech business part of the AstraZeneca Group, might be for you. We are...

Are you ready to be part of the future of healthcare? Can you think big, be bold, and harness the power of digital and AI to tackle one of the most stubborn problems in regulated software engineering — knowing, with confidence, that what you shipped works? Then Evinova, a health tech business part of the AstraZeneca Group, might be for you. We are...

It currently takes over **10 years and $1.3B** to develop a drug. More than 70% of that investment goes into clinical trials, yet only ~10% of candidates make it from Phase I to approval. **Evinova** a new health-tech business is here to change the math. We use advanced algorithms and GenAI to aim high: boosting clinical trial success by **20%**,...

It currently takes over **10 years and $1.3B** to develop a drug. More than 70% of that investment goes into clinical trials, yet only ~10% of candidates make it from Phase I to approval. **Evinova** a new health-tech business is here to change the math. We use advanced algorithms and GenAI to aim high: boosting clinical trial success by **20%** ,...

It currently takes over **10 years and $1.3B** to develop a drug. More than 70% of that investment goes into clinical trials, yet only ~10% of candidates make it from Phase I to approval. **Evinova** a new health-tech business is here to change the math. We use advanced algorithms and GenAI to aim high: boosting clinical trial success by **20%**,...

It currently takes over **10 years and $1.3B** to develop a drug. More than 70% of that investment goes into clinical trials, yet only ~10% of candidates make it from Phase I to approval. **Evinova** a new health-tech business is here to change the math. We use advanced algorithms and GenAI to aim high: boosting clinical trial success by **20%**,...

Posted date Aug. 11, 2026 Contract type Full time Job ID R-257927 ## **Why choose AstraZeneca Spain?** AstraZeneca Spain is a rising force in our global business. With headquarters in Madrid and our global hub in Barcelona, we’ve become an important international centre of excellence in the fight against critical disease. Boasting vibrant...